Akcea Therapeutics, Inc. Current Foreign Tax Expense (Benefit)
Akcea Therapeutics, Inc. reported Current Foreign Tax Expense (Benefit) of $413.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2020-03-02
- Akcea Therapeutics, Inc. current foreign tax expense (benefit) for fiscal 2019 was $413.00K, a 10.43% increase from fiscal 2018.
- Akcea Therapeutics, Inc. current foreign tax expense (benefit) for fiscal 2018 was $374.00K, a 59.83% increase from fiscal 2017.
- Akcea Therapeutics, Inc. current foreign tax expense (benefit) for fiscal 2017 was $234.00K.
- Akcea Therapeutics, Inc. current foreign tax expense (benefit) for fiscal 2016 was $0.00.
| Period end | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|
| 2019-12-31 | $413.00K 10-K · filed 2020-03-02 |
| 2018-12-31 | $374.00K 10-K · filed 2020-03-02 |
| 2017-12-31 | $234.00K 10-K · filed 2020-03-02 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-01 |
| 2015-12-31 | $0.00 8-K · filed 2018-09-18 |